The pharmaceutical industry identifies APIs as the core substances causing the therapeutic effect of the drug. APIs manufacturing in India is one of the significant global players from that country, and it contributes to the supply chain for product delivery to both domestic and international supply chains.
The basis for the importance of API manufacturers lies in the highly developed network of research and development centers, the skilled workforce, and costefficient production capabilities of India. India is one of the biggest producers of generics worldwide. Its API sector supports this by providing top-quality ingredients at competitive prices, thus positioning India as one of the key suppliers to many countries, thereby enhancing global access to essential medicines.
Increased regulatory scrutiny and quality assurance efforts of pharmaceutical manufacturing prompted Indian API manufacturers to invest in advanced technologies, operated according to international standards. This would ensure that quality built into APIs would go through into the final pharmaceutical product, thus building India's reputation and ensuring safety and efficacy for finalproduct users. This growth will only increase globally, and especially in emerging markets, the growth of pharmaceutical demand.
Consequently, the contribution of API manufacturers in India is sure to increase, holding the essential key to sustaining...
Our subscribers play a decisive role in finalization of our annual list of Top 10 Active Pharmaceutical Ingredients Manufacturers In India – 2024 by nominating those which have served them with excellence and are praiseworthy. If you feel there is a company that deserves to be on our annual list, do write to us about them mentioning their value proposition.
 | Aurobindo Pharma | The company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries |
 | Biophore | The company has bagged key clients in oncology, rare diseases and contrast media, and also offers a comprehensive range of innovatively created products to meet the requirements of markets that require APIs with high entry barriers |
 | Dr. Reddy’s Laboratories | Offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC pharmaceutical products around the world |
 | Hubert Healthcare | The firm is innovating quality pharmaceutical solutions with a customer-centric approach, ensuring affordability and precision in the pharmaceutical landscape. It develops, manufactures, and distributes APIs across various therapeutic areas |
 | Lupin | With a specialized portfolio that includes branded and generic formulations, biologic products and active pharmaceutical ingredients, the company leads in India, the U.S., and other key markets |
 | Natco Pharma | A vertically integrated pharmaceutical company focused R&D, involved in creating, producing, and promoting FDF and APIs, markets and distribute its products in over 50 countries |
 | SIONC Pharmaceutical | Specializing in the production of complex and niche APIs across various therapeutic categories, also the firm continues to gain recognition among international manufacturers as a key contributor to global healthcare |
 | Sun Pharmaceutical Industries | A specialized generic pharmaceutical firm produces and distributes a wide range of pharmaceutical formulations that address various chronic and acute treatment needs |
 | Torrent Pharmaceuticals | The company specializes in therapeutic areas including Cardiovascular CNS, GI, VMN, and Cosmo-Dermatology, with a focus on diabetology, pain management, gynecology, oncology, and anti-infective treatments |
 | Zydus Group | With in-depth domain expertise in the field of healthcare, it has strong capabilities across the pharmaceutical value chain, including formulations, active ingredients, animal healthcare, and wellness products |
